This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q70852041
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en febreru de 1984 scientific article published on 01 February 1984 գիտական հոդված հրատարակված 1984 թվականի փետրվարի 1-ին im Februar 1984 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в лютому 1984
p:P577
wds:Q70852041-EF58CB3B-C7F3-479A-B940-B90DB4D95387
wdt:P577
1984-02-01T00:00:00Z
p:P2093
wds:Q70852041-FB15FF67-5DB2-40B0-B8DD-84035013B50F
wdt:P2093
Reich SD
rdfs:label
The clinical application of drug dosing schedules in cancer therapy--Part II The clinical application of drug dosing schedules in cancer therapy--Part II The clinical application of drug dosing schedules in cancer therapy--Part II
skos:prefLabel
The clinical application of drug dosing schedules in cancer therapy--Part II The clinical application of drug dosing schedules in cancer therapy--Part II The clinical application of drug dosing schedules in cancer therapy--Part II
schema:name
The clinical application of drug dosing schedules in cancer therapy--Part II The clinical application of drug dosing schedules in cancer therapy--Part II The clinical application of drug dosing schedules in cancer therapy--Part II
p:P1476
wds:Q70852041-0F33F037-A55D-413A-827D-DE82ED62FC52
wdt:P1476
The clinical application of drug dosing schedules in cancer therapy--Part II
p:P304
wds:Q70852041-738D8BA5-B646-44C9-A668-3F1EAB171F03
wdt:P304
59-61
p:P31
wds:Q70852041-FAFF668A-14B2-48DD-9206-4FD0C42FE1EE
wdt:P31
wd:Q13442814
p:P698
wds:Q70852041-9103C1B1-688F-43ED-A7BD-9149C8DE8CF7
wdtn:P698
n10:6559098
wdt:P698
6559098
p:P1433
wds:Q70852041-3AE55E57-83BE-43BC-AADA-8ECB10E6E295
wdt:P1433
wd:Q15754460
p:P433
wds:Q70852041-A5E4BD9D-9798-4AC6-9540-B6159533AE5D
p:P478
wds:Q70852041-1755A425-2D9D-46B9-88A8-DAD950D3AD24
wdt:P433
1
wdt:P478
7